Biotricity, Inc. BTCY
0.05 USD -0.01 (-10.17%)
Nov 2, 2026, 2:05 PM EST
0.0521 Day range 0.055
0.0409 52-week range 0.59
- YTD
- -82.63%
- 1 year
- -90.86%
- Market cap
- 1.05M
- Revenue (ttm)
- 12.24M
- Profit margin
- -117.41%
- EPS (ttm)
- -0.13
- Shares out
- 22.45M
- Forward P/E
- -0.96
- YTD return
- -82.63%
- 1-year return
- -90.86%
- Volume
- 6.16K
- Avg volume
- 42.84K
- Open
- 0.055
- Previous close
- 0.058
- Day's range
- 0.0521 – 0.055
- 52-week range
- 0.0409 – 0.59
- Beta
- 1.36
- Analysts
- Hold
1M +0.0021 (+4.20%)
Key statistics
- Enterprise value
- 35.30M
- PEG ratio
- 0.00
- Price / sales
- 0.77
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 6.00%
- Free cash flow
- -4.35M
- Total cash
- 662.98K
- Total debt
- 23.09M
- Return on equity
- 0.00%
- Short % of float
- 2.31%
- 50-day average
- 0.660471
- 200-day average
- 1.00
Analyst view
Consensus: hold
Hold
Price target (mean) —
Ratings (-1m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
BTCY Revenue — quarterly 3.18M
BTCY Net income — quarterly -4.18M
BTCY EPS — quarterly -0.469
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -0.07 | — | — |
| Aug 19, 2024 | Jun 1, 2024 | 0.00 | -0.49 | — | — |
| Jun 26, 2024 | Mar 1, 2024 | -0.36 | -0.47 | -0.11 | -30.56% |
| Feb 20, 2024 | Dec 1, 2023 | -0.41 | -0.34 | +0.07 | +17.07% |
| Nov 14, 2023 | Sep 1, 2023 | -0.34 | -0.44 | -0.10 | -29.41% |
| Aug 14, 2023 | Jun 1, 2023 | -0.41 | -0.07 | +0.34 | +82.93% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 4, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
About Biotricity, Inc.
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. Biotricity, Inc. is based in Redwood City, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- biotricity.com
News
Biotricity, Inc to Present at the LD Micro Invitational XVI 
Financial Survey: 10x Genomics (NASDAQ:TXG) and Biotricity (OTCMKTS:BTCY) 
Biotricity, Inc. (BTCY) Q3 2026 Earnings Call Transcript 
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA 
Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th 
Comparing Biotricity (OTCMKTS:BTCY) & 111 (NASDAQ:YI) 
Head-To-Head Analysis: Zepp Health (NYSE:ZEPP) versus Biotricity (OTCMKTS:BTCY) 
3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run 
Biotricity, Inc. (BTCY) Q2 2026 Earnings Call Transcript 
Biotricity Inc. (BTCY) Reports Q2 Loss, Lags Revenue Estimates
Your note
Sign in to keep a note on BTCY — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BETTS NORMAN MURRAY PH.D. | Director | Stock Award(Grant) | Nov 28, 2021 | 375,598 |
| BETTS NORMAN PH.D. | Director | Stock Award(Grant) | Apr 6, 2020 | 321,250 |
| KENNEDY PATRICIA J | Director | Stock Award(Grant) | Apr 6, 2020 | 250,000 |
| ROSA DAVID A | Director | Stock Award(Grant) | Nov 28, 2021 | 152,174 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 2.89% | 247,211 | 945.58K | Jun 29, 2023 |
| Geode Capital Management, LLC | 0.75% | 64,034 | 244.93K | Jun 29, 2023 |
| Strengthening Families & Communities, LLC | 0.56% | 48,263 | 184.60K | Jun 29, 2023 |
| AE Wealth Management LLC | 0.49% | 41,684 | 89.20K | Sep 29, 2023 |
| State Street Corporation | 0.26% | 22,549 | 86.25K | Jun 29, 2023 |
| Blackrock Inc. | 0.16% | 13,374 | 51.16K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.65% | 140,956 | 539.16K | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 1.07% | 91,890 | 351.48K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.41% | 35,034 | 145.04K | May 30, 2023 |
| Fidelity Total Market Index Fund | 0.12% | 9,985 | 41.34K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.09% | 8,001 | 33.12K | May 30, 2023 |
| Vanguard Balanced Index Fund | 0.08% | 7,133 | 27.28K | Jun 29, 2023 |